{"id":11442,"date":"2026-07-09T23:31:49","date_gmt":"2026-07-09T23:31:49","guid":{"rendered":"https:\/\/www.fintechpulse8.com\/?p=11442"},"modified":"2026-07-09T23:31:49","modified_gmt":"2026-07-09T23:31:49","slug":"teva-pharmaceutical-industries-limited-teva-discusses-anti-il-15-antibody-phase-ib-24-week-efficacy-results-in-vitiligo-and-planned-advancement-to-phase-2b-slideshow","status":"publish","type":"post","link":"https:\/\/www.fintechpulse8.com\/?p=11442","title":{"rendered":"Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b &#8211; Slideshow"},"content":{"rendered":"<p>Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b &#8211; Slideshow#Teva #Pharmaceutical #Industries #Limited #TEVA #Discusses #AntiIL15 #Antibody #Phase #24Week #Efficacy #Results #Vitiligo #Planned #Advancement #Phase #Slideshow<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b &#8211; Slideshow#Teva #Pharmaceutical #Industries #Limited #TEVA #Discusses #AntiIL15 #Antibody&hellip; <\/p>\n","protected":false},"author":1,"featured_media":5445,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[242],"tags":[12978,12981,12977,12976,1587,12979,2269,1002,5500,3222,8600,740,700,11549,12980],"class_list":["post-11442","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-editors-pick","tag-24week","tag-advancement","tag-antibody","tag-antiil15","tag-discusses","tag-efficacy","tag-industries","tag-limited","tag-pharmaceutical","tag-phase","tag-planned","tag-results","tag-slideshow","tag-teva","tag-vitiligo"],"_links":{"self":[{"href":"https:\/\/www.fintechpulse8.com\/index.php?rest_route=\/wp\/v2\/posts\/11442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fintechpulse8.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fintechpulse8.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fintechpulse8.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fintechpulse8.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11442"}],"version-history":[{"count":0,"href":"https:\/\/www.fintechpulse8.com\/index.php?rest_route=\/wp\/v2\/posts\/11442\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fintechpulse8.com\/index.php?rest_route=\/wp\/v2\/media\/5445"}],"wp:attachment":[{"href":"https:\/\/www.fintechpulse8.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fintechpulse8.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fintechpulse8.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}